Phase 2 Randomized, Controlled, Human Influenza A (H1N1) Challenge Study Following Administration of an Oral H1N1 HA Adenoviral-Vector Based Seasonal Influenza Vaccine and dsRNA Adjuvant to Healthy Adult Volunteers
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Influenza A virus H1N1 vaccines (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- Sponsors Vaxart
- 26 Oct 2017 Status changed from recruiting to completed, according to a Vaxart media release.
- 26 Oct 2017 Results published in a Vaxart Media Release.
- 01 Oct 2016 New trial record